1-(2-Chloroethyl)-4-ethyl-1H-tetrazol-5(4H)-one, 95.0%, 250mg

7-ACETOXY-4-METHYLCOUMARIN, 97.0%, 100g

6-Chloro-4-methyl-1H-pyrazolo[3,4-d]pyrimidine, 98%, 1g

1-(4-Methoxyphenyl)cyclopropan-1-amine hydrochloride, 95.0%, 1g

Potassium formate, min. 98%, for synthesis, 250 g, plastic packaging.

Methyl 6-fluoro-2-methylnicotinate, 95.0%, 1g

7-Formyl-8-quinolinol, 95.0%, 500mg

3-iodo-1,4-dimethyl-1H-indazole, 95.0%, 1g

N-[(1S,2S)-2-Amino-1,2-bis(4-methoxyphenyl)ethyl]-4-methylbenzenesulfonamide, 97%, 250mg

Lenalidomide-C4-NH2 (hydrochloride), 500mg

N-(2-(Pyridin-2-yl)benzyl)propan-2-amine, 95%, 250mg

Cyclopropylmethanesulfonyl chloride, 95.0%, 250mg

(S)-tert-Butyl 2-(6-(benzyloxy)-2-(tert-butoxycarbonylamino)hexyloxy)acetate, 95%, 1g